From Small Molecules to Large Biologics: a look at the impact of relative size and complexity and how it impacts the biosimilar debate in the states.
Category Archives: AZBio News
Arizona’s Biosimilar Bill Goes to Committee This Week
A letter to our Arizona Legislators on Arizona’s Biosimilars BillContinue reading
Biocentury This Week Looks at Venture Capital
No one doubts the venture capital world is shrinking for life sciences.
But at least 345 venture stage biotechs around the world closed VC deals worth more than $6 billion last year. It was the second highest total in the past decade. And the total has not fallen below $5 billion in that time.Continue reading
Forbes Ranks SynCardia Among “America’s Most Promising Companies” for Second Year
SynCardia Sets New Monthly Record for Total Artificial Heart Implants in JanuaryContinue reading
UA Study: Can a Sensor Prevent Diabetic Foot Amputation?
A researchers are working with a small business partner to design an innovative technology aimed at boosting diabetic patients’ adherence to prescribed footwear.Continue reading
Establishing A Framework For Growth
What will it take to take the Arizona biotech industry to the next level in the coming decade?Continue reading
BioCentury This Week: On The Brink of Disunioun
When President Obama delivers the State of the Union address on Tuesday, he’ll be speaking to a polarized Congress where brinksmanship is the order of the day. If lawmakers don’t act by March 1, budget sequestration will slash funding for biomedical research and oversight of the nation’s food and drug products. Continue reading
ABOR Supports Budget Plan, University Funding Request
Resolution supports increased finacial contributions by the state to fund resarch and medical education programsContinue reading
Arizona bioscience jobs continue rapid growth during economic recovery
Arizona’s bioscience sector added jobs at nearly four times the national rate over the past decade and experienced double-digit job growth during the economic recovery, according to a new report from Battelle Technology Partnership Practice that outlines the 2012 progress of Arizona’s Bioscience Roadmap.Continue reading
Decades of Progress with More to Come
Over four decades ago, President Richard Nixon signed the National Cancer Act and the “War on Cancer” was engaged. Now as we look at the progress that has been made and the progress yet to come, executives from PhRMA share the recent results of a study released on over 5000 new drugs in the biopharma pipeline that are taking us forward in the war against cancer and other diseases.Continue reading